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The classical monoamine theory of depres-
sion states that depression may be caused by a
central deficiency of biogenic amines, particu-
larly norepinephrine and serotonin. It has been
proposed that effective antidepressant therapies
work by correcting the central deficiency in bio-
genic amines and reequilibrate monoaminergic
systems in the direction of greater efficiency.
The transplantation of pharmacologically rele-
vant tissues to specific CNS sites is a novel
approach toward restoring imbalanced func-
tioning in the CNS. The aim of this study was to
determine whether the transplantation of
monoamine-producing tissues into the frontal
neocortex of rats could alleviate depression in
animal models.
In the first study, male Sprague-Dawley rats
were transplanted with either catecholamine-
rich adrenal medulla, serotonin-rich pineal
gland, a combination of both adrenal medulla
and pineal gland, or an equal volume of striated
muscle as a control implant that did not produce
monoamines. The tissue was implanted stereo-
taxically into the frontal neocortex, a site shown
previously to be a potent cortical site of action
for antidepressant activity.
Six to eight weeks following surgery rats were
assessed behaviorally using the Learned Help-
lessness (LH) model of depression. LH is widely
considered to be one of the most reliable animal
models of depression and is induced by exposure
to inescapable and uncontrollable stress which
results in deficits in subsequent performance
when the stress is escapable and controllable.
These deficits can be prevented by antidepres-
sant therapies, such as imipramine. At different
periods following termination of LH behavioral
testing graft tissues were assessed morphologi-
cally using immunocytochemistry. Results of this
first study revealed that LH was prevented in all
three experimental monoamine implant groups
but not prevented in the control muscle
implanted rats. Immunoeytoehemical results
show that the grafts survived well and continued
to produce monoamines for periods up to six
months.
In part two of the study, female Sprague-
Dawley rats were assessed using the Forced
Swimming Test (FST), a popular measure of
antidepressant activity. In the FST rats are
forced to swim in a onfined plexiglass cylinder
and after an initial energetic attempt to escape
they assume a readily identifiable immobile
posture. On subsequent immersion the rat as-
sumes the immobile position more rapidly and
the duration of immobility is recorded over a
five minute period. This duration of immobility
is significantly reduced by a wide variety of
antidepressant treatments. Rats in this study
were assessed using the FST immediately prior
to surgery to determine baseline immobility
scores. Next, rats were transplanted to the
frontal cortex with either adrenal medullary
tissue, pineal gland tissue or equal volumes of
sciatic nerve. Sciatic nerve served as a control
tissue that produces trophic factors but does not
produce monoamines. A control non-implanted
group was also used in this experiment. Six to
eight weeks following transplantation rats were
again assessed behaviorally with the FST and
immobility scores were recorded. Following the
termination of FST testing (eight weeks follow-
ing graft implantation), blocks of cortical tissue,
including the transplant region, were dissected
out and extracted and analyzed for monoamine
concentrations using high performance liquid
chromatography (HPLC).
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Results from this study revealed that follow-
ing transplantation, both pineal and adrenal
medullary transplants significantly lowered
immobility scores. In contrast to the monoamine
transplant groups, the mean immobility scores
for the sciatic nerve group and the non-
implanted group were not reduced from FST
immobility scores prior to transplantation.
Biochemical results showed that serotonin levels
and norepinephrine levels, in the pineal
implanted group and adrenal medullary im-
planted group, respectively, were significantly
higher than both the sciatic implanted and the
non-implanted groups.
In conclusion, these studies suggest that
monoaminergic neural transplants can provide a
local source of monoamines for antidepressive
action. The ability of monoaminergic grafts to
alleviate depression in two different animal
models is a promising finding that adds credence
to the possibility of monoaminergic neural
transplants providing a new approach to the
treatment of clinical depression.